ArticleCardiovascular research2025

RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study.

Eloi Gagnon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.